| Literature DB >> 29097775 |
Zhen Tan1, Yuan Wang1, Ting Yang1, Kai Xing1, Hong Ao2, Shaokang Chen3, Fengxia Zhang1, Xitong Zhao1, Jianfeng Liu1, Chuduan Wang4.
Abstract
The feed conversion ratio (FCR) is an essential economic trait for pig production, and is directly related to feed efficiency. Studies identifying the differential expression of functional genes involved in biological and molecular mechanisms in the intestine in relation to growth performance are rare. In this study, RNA-Seq was used to identify transcriptomes in caecal and colonic mucosal tissues in order to determine the differential expression of genes from two full-sibling pairs and two half-sibling pairs of Landrace finishing pigs with opposing FCR phenotypes. In total, 138 (comparison of high and low FCR in caecal mucosa), 64 (comparison of high and low FCR in colonic mucosa), and 165 (contrast between the caecal and colonic mucosa) differentially expressed genes were identified. Some of these genes were functionally related to energy and lipid metabolism, particularly short chain fatty acids metabolism, as well as gastrointestinal peristalsis and ion transport. Functional annotation were performed to identify differentially expressed genes, such as GUCA2A, GUCA2B, HSP70.2, NOS2, PCK1, SLCs, and CYPs, which may positively influence feed efficiency in Landrace pigs. These differentially expressed genes need to be further tested for candidate genes that are related to feed efficiency.Entities:
Mesh:
Year: 2017 PMID: 29097775 PMCID: PMC5668291 DOI: 10.1038/s41598-017-14568-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
RNA sequencing of mRNA from the caecal and colonic mucosa of Landrace female finishing pigs with high and low FCR.
| Group | Sample | Total reads (million) | Total mapped reads (%) | Unique matched reads (%) | Multi matched reads (%) | CDS exons (%) | 5′UTR exons (%) | 3′UTR exons (%) | Intron (%) | Intergenic (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Hce | H1caecum | 53.58 | 72.70 | 68.45 | 4.26 | 64.57 | 1.45 | 12.28 | 8.04 | 13.66 |
| H2caecum | 52.68 | 71.05 | 66.83 | 4.22 | 69.85 | 1.73 | 10.91 | 5.52 | 11.99 | |
| H3caecum | 51.18 | 71.55 | 67.36 | 4.19 | 64.88 | 1.44 | 11.93 | 8.04 | 13.71 | |
| H4caecum | 58.62 | 71.04 | 66.91 | 4.12 | 58.72 | 1.05 | 12.76 | 11.57 | 15.91 | |
| Lce | L1caecum | 61.19 | 72.94 | 68.69 | 4.25 | 67.88 | 1.68 | 11.45 | 6.44 | 12.55 |
| L2caecum | 48.72 | 73.00 | 68.68 | 4.32 | 66.26 | 1.59 | 12.00 | 6.67 | 13.48 | |
| L3caecum | 66.97 | 72.90 | 68.62 | 4.28 | 68.15 | 1.67 | 11.26 | 6.36 | 12.56 | |
| L4caecum | 58.57 | 70.56 | 66.37 | 4.20 | 65.84 | 1.54 | 11.12 | 7.98 | 13.51 | |
| Hco | H1colon | 69.50 | 71.48 | 67.12 | 4.36 | 68.89 | 1.72 | 11.04 | 6.00 | 12.35 |
| H2colon | 77.40 | 70.15 | 65.82 | 4.33 | 69.16 | 1.77 | 10.53 | 6.22 | 12.32 | |
| H3colon | 69.08 | 70.01 | 65.71 | 4.30 | 64.42 | 1.54 | 10.86 | 9.06 | 14.13 | |
| H4colon | 54.37 | 73.02 | 68.90 | 4.12 | 65.32 | 1.38 | 12.35 | 7.42 | 13.54 | |
| Lco | L1colon | 64.75 | 69.24 | 64.83 | 4.41 | 68.20 | 2.00 | 9.26 | 7.71 | 12.83 |
| L2colon | 60.30 | 72.25 | 67.90 | 4.35 | 64.69 | 1.51 | 11.38 | 8.25 | 14.17 | |
| L3colon | 69.99 | 69.84 | 65.49 | 4.34 | 68.86 | 1.84 | 9.51 | 7.22 | 12.56 | |
| L4colon | 63.21 | 72.54 | 68.28 | 4.28 | 66.03 | 1.61 | 11.80 | 7.22 | 13.35 |
Uses Sus scrofa 10.2 as the reference genome annotation to classify the mapping tags to the different regions. Hce, caecal samples of HFCR group; Lce, caecal samples of LFCR group. Hco, colonic samples of HFCR group; Lco, colonic samples of LFCR group.
Figure 1Venn diagrams representing gene expression in four groups of pigs. Levels of gene expression in the caecal and colonic mucosa of pigs with high or low FCR: Hcaecum and Lcaecum (a), Hcolon and Lcolon (b), Hcaecum and Hcolon (c), and Lcaecum and Lcolon (d) are shown. The total number of expressed genes in each group is shown. The number of common genes is shown in the overlapping segments.
Figure 2Venn diagrams showing DEGs between the caecal and colonic mucosa in the high and low FCR groups.
List of 40 differentially expressed genes (DEGs) between caecal mucosa with high and low FCR.
| Gene | Locus | FPKM_Hce | FPKM_Lce | Log2(Fold change) | q_value | Gene description |
|---|---|---|---|---|---|---|
| GUCA2A | 6:156476367-156478316 | 1822.97 | 641.96 | −1.51 | 6.16E-03 | Guanylin |
| HSP70.2 | GL896522.1:2-1799 | 1450.72 | 417.43 | −1.80 | 3.40E-03 |
|
| ISG12(A) | 7:122215477-122220545 | 1395.64 | 417.83 | −1.74 | 3.40E-03 | interferon, alpha-inducible protein 27 |
| UBD | 7:25330260-25332807 | 1242.79 | 287.87 | −2.11 | 3.40E-03 | ubiquitin D |
| IGLV-11 | 14:52228869-52229344 | 1169.88 | 534.43 | −1.13 | 1.52E-02 | immunoglobulin lambda variable 11 |
| S100G | X:13996225-14092759 | 1043.02 | 312.73 | −1.74 | 6.16E-03 | S100 calcium binding protein G |
| ASS1 | 1:304454128-304508998 | 877.10 | 234.95 | −1.90 | 3.40E-03 | argininosuccinate synthase 1 |
| IGLV-2 | 14:52404074-52404828 | 564.54 | 191.16 | −1.56 | 3.40E-03 | immunoglobulin lambda variable 2 |
| MS4A12 | 2:10736890-10753331 | 530.87 | 254.17 | −1.06 | 1.90E-02 | membrane spanning 4-domains A12 |
| CLDN4 | 3:10776891-10780656 | 236.74 | 101.29 | −1.22 | 3.40E-03 | claudin 4 |
| HBB | 9:5632714-5634344 | 235.47 | 93.61 | −1.33 | 3.40E-03 | hemoglobin, beta |
| GZMB | 7:79831196-79834605 | 204.96 | 97.37 | −1.07 | 1.52E-02 | granzyme B |
| UBE2L6 | 2:12987516-13002993 | 177.71 | 83.94 | −1.08 | 3.40E-03 | ubiquitin conjugating enzyme E2L 6 |
| ISG15 | GL895967.2:58448-59139 | 139.46 | 29.59 | −2.24 | 3.40E-03 | ISG15 ubiquitin-like modifier |
| GZMA | 16:36385657-36393941 | 117.24 | 48.25 | −1.28 | 3.40E-03 | granzyme A |
| GNLY | 3:61952961-61957608 | 114.36 | 52.31 | −1.13 | 3.40E-03 | antimicrobial peptide NK-lysin precursor |
| GBP2 | 4:139612346-139633862 | 112.97 | 44.49 | −1.34 | 3.40E-03 | guanylate binding protein 2, interferon-inducible |
| NOS2 | 12:46022453-46053026 | 103.76 | 35.61 | −1.54 | 3.40E-03 | nitric oxide synthase 2 |
| SLC30A10 | 10:11615849-11627111 | 85.04 | 36.22 | −1.23 | 3.40E-03 | solute carrier family 30 member 10 |
| ENTPD8 | 1:314009380-314012067 | 78.46 | 39.17 | −1.00 | 3.40E-03 | ectonucleoside triphosphate diphosphohydrolase 8 |
| PLEKHG6 | 5:66793344-66811338 | 66.27 | 28.88 | −1.20 | 6.16E-03 | pleckstrin homology and RhoGEF domain containing G6 |
| ANPEP | 7:60240144-60262914 | 64.18 | 22.43 | −1.52 | 1.10E-02 | alanyl aminopeptidase, membrane |
| SLA-7 | 7:27613956-27617558 | 63.35 | 27.62 | −1.20 | 3.40E-03 | MHC class I antigen 7 |
| KIFC2 | 4:415602-422897 | 58.43 | 24.88 | −1.23 | 3.40E-03 | kinesin family member C2 |
| OAS1 | 14:41230164-41288614 | 58.41 | 25.10 | −1.22 | 4.19E-02 | 2′-5′-oligoadenylate synthetase 1 |
| 7SK | 7:134400748-134401079 | 54.67 | 22.78 | −1.26 | 2.47E-02 | 7SK RNA |
| IGSF23 | 6:47050121-47057994 | 51.73 | 15.06 | −1.78 | 3.40E-03 | immunoglobulin superfamily member 23 |
| PARP15 | 13:147507154-147531686 | 45.23 | 6.90 | −2.71 | 3.40E-03 | poly(ADP-ribose) polymerase family member 15 |
| C4BPA | 9:74195615-74207951 | 39.17 | 17.67 | −1.15 | 3.74E-02 | complement component 4 binding protein alpha |
| SLC14A1 | 1:105418611-105444533 | 37.42 | 8.04 | −2.22 | 3.40E-03 | solute carrier family 14 member 1 |
| OASL | 14:43414433-43431814 | 30.69 | 7.16 | −2.10 | 3.40E-03 | 2′-5′-oligoadenylate synthetase-like |
| FRMD1 | 1:2657896-2672308 | 11.75 | 3.31 | −1.83 | 3.40E-03 | FERM domain containing 1 |
| IGKV-3 | 3:59934903-59935620 | 110.74 | 732.09 | 2.72 | 3.40E-03 | immunoglobulin kappa variable 3 |
| IGLV-4 | 14:52392751-52393255 | 68.83 | 552.68 | 3.01 | 3.40E-03 | immunoglobulin lambda variable 4 |
| CH242-307A4.1 | 3:67957189-67973255 | 48.89 | 337.90 | 2.79 | 3.40E-03 | lithostathine-like precursor |
| IGLV-5 | 14:52384767-52385271 | 27.55 | 171.00 | 2.63 | 3.40E-03 | immunoglobulin lambda variable 5 |
| PIGR | 9:73889671-73899096 | 71.17 | 150.36 | 1.08 | 3.40E-03 | polymeric immunoglobulin receptor precursor |
| REG3G | 3:68078690-68081405 | 5.92 | 129.41 | 4.45 | 3.40E-03 | regenerating islet-derived 3 gamma |
| C4BPA | 9:74110908-74154259 | 45.63 | 104.31 | 1.19 | 3.40E-03 | complement component 4 binding protein alpha |
| CHAC1 | 1:145522852-145525603 | 2.49 | 64.03 | 4.68 | 3.40E-03 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 |
List of 13 differentially expressed genes (DEGs) between colonic mucosa with high and low FCR.
| gene | locus | FPKM_Hco | FPKM_Lco | log2(fold_change) | q_value | Gene description |
|---|---|---|---|---|---|---|
| TRPV6 | 18:7636964-7652271 | 14.71 | 1.73 | −3.09 | 3.40E-03 | transient receptor potential cation channel subfamily V member 6 |
| SPINK1 | 2:155635124-155640264 | 32976.60 | 10332.90 | −1.67 | 3.40E-03 | serine peptidase inhibitor, Kazal type 1 |
| IGLV-2 | 14:52404074-52404828 | 303.47 | 112.61 | −1.43 | 3.40E-03 | immunoglobulin lambda variable 2 |
| TMEM120A | GL894019.2:55427-61934 | 42.33 | 16.05 | −1.40 | 3.40E-03 | transmembrane protein 120A |
| CYP2B6 | 6:44929853-44978800 | 56.83 | 22.22 | −1.35 | 1.71E-02 | cytochrome P450 family 2 subfamily B member 6 |
| FRMD1 | 1:2657896-2672308 | 33.53 | 14.14 | −1.25 | 3.44E-02 | FERM domain containing 1 |
| CD209 | 2:71917404-71931695 | 24.01 | 55.44 | 1.21 | 3.40E-03 | CD209 molecule |
| SLC2A13 | 5:73929816-74023533 | 39.91 | 105.25 | 1.40 | 3.40E-03 | solute carrier family 2 member 13 |
| CH242-307A4.1 | 3:67957189-67973255 | 3.18 | 9.41 | 1.56 | 1.32E-02 | lithostathine-like precursor |
| IGLV-5 | 14:52384767-52385271 | 22.54 | 90.57 | 2.01 | 3.40E-03 | immunoglobulin lambda variable 5 |
| IGKV-3 | 3:59934903-59935620 | 39.11 | 169.95 | 2.12 | 6.16E-03 | immunoglobulin kappa variable 3 |
| IGLV-4 | 14:52392751-52393255 | 26.33 | 226.01 | 3.10 | 3.40E-03 | immunoglobulin lambda variable 4 |
| CHAC1 | 1:145522852-145525603 | 1.16 | 10.11 | 3.13 | 3.40E-03 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 |
Figure 3Enriched GO terms and the number of corresponding DEGs for each term in the Hce vs Lce group.
Figure 4Relationship between DEGs, pathways, and GO terms of Hce vs Lce. Functional association analysis performed by ToppCluster based on pathway networks showing enriched terms from Gene Ontology and pathways. The top part of the figure depicts significant enrichments for up-regulated DEGs in Hce compared with Lce; the lower part depicts significant enrichments for down-regulated DEGs in Hce compared with Lce. Red hexagon: DEG; green square: pathways; blue square: biological processes; grey square: molecular functions.
Figure 5STRING analysis shows that DEGs are involved in known and predicted protein-protein interactions. STRING is used to analyse DEGs in the mucosa of Hce and Lce. The network nodes stand for those genes shown in Tables S3 and S4. Different coloured lines represent seven types of evidence used to predict associations. Red line: fusion evidence; green line: neighbourhood evidence; blue line: co-occurrence evidence; purple line: experimental evidence; yellow line: text mining evidence; light blue line: database evidence and black line: co-expression evidence.